SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
US measles cases surpass 2,000, highest in 30 years: CDC - 2Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- 3Why don’t humans have hair all over their bodies? A biologist explains our lack of fur
- 4Artemis 2 astronauts arrive at Kennedy Space Center ahead of NASA's historic launch around the moon
- 5Can humans have babies in space? It may be harder than expected
- True to life Authenticity d: A Survey of \Certifiable Stories\ Narrative
- Share your number one city visit transport that leaves a mark on the world wake up!
- Chinese fossils reveal a primordial burst of animal evolution
- Are Saturn's rings made of a lost, shattered moon? New evidence arises for the case
- Oldest evidence of human fire-making discovered at site in England
- Vote in favor of the Top Vegetable for Senior
- An Aide On Upgrading Your FICO rating
- Manual for Vegetarian Protein Powder
- Countdown begins for long-awaited Artemis II moon mission
